Track the 佰仁医疗 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 佰仁医疗 has published 18 insider filings. Market capitalisation: €14.7bn. The latest transaction was disclosed on 2 January 2025 (Purchase). Among the most active insiders: 吴嘉. Every trade is free.
18
Insider Decl.
0
Thresholds
€398,052
6 ops.
Buy Volume
€138,684
12 ops.
Sell Volume
10Σ signal
Buys €398,052€138,684 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,021 of 26,213 companies
57.7
score / 100
Value
29
Quality
87
FCF yld0.5%
Earn yld1.5%
EV/EBITDA50.6x
ROE15%
Gross mgn89%
Net mgn31%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
